SVA

Sinovac Biotech, Ltd
SVA

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

SVA was delisted on the 22nd of February, 2019.

Back to rankings

36 hedge funds and large institutions have $66.9M invested in Sinovac Biotech, Ltd in 2016 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 12 increasing their positions, 13 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
36
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$793K
2
+$466K
3
+$424K
4
Two Sigma Investments
Two Sigma Investments
New York
+$203K
5
VAM
Verity Asset Management
North Carolina
+$175K

Top Sellers

1
-$2.61M
2
-$2M
3
-$1.03M
4
USAA
United Services Automobile Association
Texas
-$73K
5
SIM
Spark Investment Management
New York
-$61K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$48K
27
$27K
28
$23K
29
$16K
30
$14K
31
$7K
32
$6K
33
$6K
34
$3K
35
$3K
36
$2K
37
–
38
–
39
–
40
–
1
2